AI assistant
PETROFAC LD — Director's Dealing 2019
Jan 7, 2019
5194_dirs_2019-01-07_4d637e17-218a-4cd4-bbdb-ba2b86da93d2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4186M
Petrofac Limited
07 January 2019
7 January 2019
Petrofac Limited (the "Company")
Notification of Transaction by
Persons Discharging Managerial Responsibilities (PDMRs)
Pursuant to Market Abuse Regulation 19, the Company hereby notifies that today, the following Directors purchased ordinary shares ("Shares") of US$0.02 each in the Company at 527.00 pence per Share on the London Stock Exchange. These purchases are in line with the Company's remuneration arrangements, as published in the 2017 Annual Report and Accounts.
| Name of Director | Position | Number of Ordinary Shares purchased on 7th January 2019 | Total cumulative disclosable interest held (Shares) |
| René Médori | Chairman | 3,795 | 9,905 |
| Andrea Abt | Non-executive Director | 948 | 3,539 |
| Sara Akbar | Non-executive Director | 948 | 3,539 |
| Matthias Bichsel | Non-executive Director | 948 | 3,539 |
| David Davies | Non-executive Director | 948 | 17,771 |
| George Pierson | Non-executive Director | 948 | 3,539 |
The Company's issued share capital consists of 345,912,747 Shares with voting rights. Each Share carries the right to one vote. The Company does not hold any shares in Treasury.
For further information contact:
Alison Flynn, Group Head of Communications
+44 (0) 207 811 4913
Jonathan Low, Head of Investor Relations
+44 (0) 207 811 4930
Tulchan Communications Group Ltd
Martin Robinson
Tel: +44 (0) 20 7353 4200
LEI 2138004624W8CKCSJ177
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHCKODNPBKDNDK